NEETPGAI
FeaturesBlogComparePricing
Log inStart Free
NEETPGAI

AI-powered NEET PG preparation platform. Master all 19 subjects with adaptive MCQs, AI tutoring, and spaced repetition.

Product

  • Features
  • Subjects
  • Previous Year Questions
  • Compare
  • Pricing
  • Blog

Features

  • Adaptive MCQ Practice
  • AI Tutor
  • Mock Tests
  • Spaced Repetition

Resources

  • Blog
  • Study Guides
  • NEET PG Updates
  • Contact & support

Legal

  • Privacy Policy
  • Terms of Service

Stay updated

© 2026 NEETPGAI. All rights reserved.
    Subjects/Pathology/Tumor Suppressor Genes
    Tumor Suppressor Genes
    medium
    microscope Pathology

    Which feature best distinguishes Li-Fraumeni syndrome (TP53 mutation) from hereditary retinoblastoma (RB1 mutation)?

    A. Multiple primary malignancies across diverse organ systems in adulthood
    B. Predisposition to osteosarcoma and soft tissue sarcomas
    C. Autosomal recessive inheritance pattern
    D. Bilateral ocular involvement in childhood

    Explanation

    Distinguishing Li-Fraumeni from Hereditary Retinoblastoma

    Key Clinical Difference
    Key Point
    Li-Fraumeni syndrome (TP53 mutation) is characterized by a broad spectrum of early-onset malignancies across multiple organ systems, whereas hereditary retinoblastoma (RB1 mutation) has a tissue-restricted phenotype primarily affecting the retina and secondarily the bone/soft tissues.
    Comparative Table
    Table
    FeatureLi-Fraumeni (TP53)Hereditary Retinoblastoma (RB1)
    Primary tumorVariable (breast, lung, colon, brain, leukemia, sarcoma)Retinoblastoma (bilateral in 40%)
    Age of onsetOften <45 years; multiple primariesRetinoblastoma <5 years; secondary sarcomas >10 years
    Tumor spectrumDiverse (>10 different cancer types)Retina + osteosarcoma/soft tissue sarcoma
    InheritanceAutosomal dominant (germline TP53)Autosomal dominant (germline RB1)
    HallmarkMultiple independent primary cancersOcular + skeletal malignancies
    Why This Matters
    High-YieldNEET PG
    TP53 is the "guardian of the genome" — loss of p53 function removes checkpoint control across all cell types, leading to pan-cancer predisposition. RB1 loss primarily affects G1/S checkpoint in retinal and bone cells, restricting the phenotype.
    Clinical Pearl
    A 35-year-old woman with breast cancer, a 40-year-old sibling with colon cancer, and a parent with early-onset leukemia → suspect Li-Fraumeni. A 3-year-old with bilateral retinal masses and a 15-year-old sibling with osteosarcoma → suspect hereditary retinoblastoma.
    Mnemonic

    TP53 = "Tumor Predisposition 53" (pan-cancer) vs. RB1 = "Retino-Bone 1" (tissue-restricted)

    Robbins 10e Ch 7

    Practice similar questions

    Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.

    Start Practicing Free More Pathology Questions

    Join our NEET PG community

    Daily MCQs, study tips, and topper strategies on Telegram.

    Join on Telegram →